Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia
Titel:
Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia
Auteur:
Kantarjian, Hagop M. Talpaz, Moshe O'Brien, Susan Giles, Francis Garcia-Manero, Guillermo Faderl, Stefan Thomas, Deborah Shan, Jianqin Rios, Mary Beth Cortes, Jorge